Aerie Pharmaceuticals
id:
aerie-pharmaceuticals-248-8331749
title:
Aerie Pharmaceuticals
text:
Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients with glaucoma or ocular hypertension. In August 2022, Swiss eye-care firm Alcon agreed to buy Aerie Pharmaceuticals for US$770 million. The acquisition c
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Aerie_Pharmaceuticals
date created:
date modified:
2023-12-10T02:09:55Z
main entity:
{"identifier":"Q25245434","url":"https://www.wikidata.org/entity/Q25245434"}
image:
fields total:
13
integrity:
13